Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Cohen

Showing results (241-250 of 272) with videos related to

Pageof 28
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2023
The discovery and evaluation of [<sup>18</sup>F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagementDavid J Donnelly, Joonyoung Kim, Tritin Tran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Synthesis and Biologic Evaluation of a Novel <sup>18</sup>F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 ExpressionDavid J Donnelly, R Adam Smith, Paul Morin, et al.
Analytical Chemistry|February 15, 2017
Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave MutagenesisJing Li, Hui Wei, Stanley R Krystek, et al.
Vaccines|February 26, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Eclinicalmedicine|September 14, 2020
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasmaYasmin Maor, Daniel Cohen, Nir Paran, et al.
Journal of Neuroscience Research|June 27, 2020
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) ratsThomas Prukop, Stephanie Wernick, Lydie Boussicault, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 8, 2025
In vivo dosimetry in head and neck cancer radiotherapy patients using an intraoral stent: prospective cohortLísia Daltro Borges Alves, Ana Carolina Dos Santos Menezes, Alfredo Viamonte Marin, et al.
American Journal of Hematology|March 28, 2019
Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive painMarcus A Carden, David C Brousseau, Fahd A Ahmad, et al.
Vaccine|October 17, 2025
Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adultsYoseph Caraco, Noa Madar-Balakirski, Eytan Ben-Ami, et al.
European Urology Oncology|January 11, 2021
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel StudyBas W G van Rhijn, Anouk E Hentschel, Johannes Bründl, et al.
Pageof 28

Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2023
The discovery and evaluation of [<sup>18</sup>F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagementDavid J Donnelly, Joonyoung Kim, Tritin Tran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Synthesis and Biologic Evaluation of a Novel <sup>18</sup>F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 ExpressionDavid J Donnelly, R Adam Smith, Paul Morin, et al.
Analytical Chemistry|February 15, 2017
Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave MutagenesisJing Li, Hui Wei, Stanley R Krystek, et al.
Vaccines|February 26, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Eclinicalmedicine|September 14, 2020
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasmaYasmin Maor, Daniel Cohen, Nir Paran, et al.
Journal of Neuroscience Research|June 27, 2020
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) ratsThomas Prukop, Stephanie Wernick, Lydie Boussicault, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 8, 2025
In vivo dosimetry in head and neck cancer radiotherapy patients using an intraoral stent: prospective cohortLísia Daltro Borges Alves, Ana Carolina Dos Santos Menezes, Alfredo Viamonte Marin, et al.
American Journal of Hematology|March 28, 2019
Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive painMarcus A Carden, David C Brousseau, Fahd A Ahmad, et al.
Vaccine|October 17, 2025
Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adultsYoseph Caraco, Noa Madar-Balakirski, Eytan Ben-Ami, et al.
European Urology Oncology|January 11, 2021
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel StudyBas W G van Rhijn, Anouk E Hentschel, Johannes Bründl, et al.
Pageof 28